The COVID-19 antibody test is for individuals who think they have antibodies (from a previous COVID-19 infection and/or vaccine) but who do not currently have symptoms. It is a finger-prick blood test.
-
OCT 19, 2022 | 6:45 AM
C.E. CREDITS
SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports t...
OCT 19, 2022 | 6:00 AM
C.E. CREDITS
Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by emerging variants including Omicron subvariants. This study evaluated safety and immunogenicity of SARS-Co...
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
SEP 08, 2022 | 6:00 AM
C.E. CREDITS
Since its discovery in late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global pandemic of coronavirus disease 2019 (COVID-19). As of July of 2022, mo...
Date: July 20, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be an international public health emergency due...
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
The COVID-19 pandemic has taken a dramatic toll worldwide. Its impact possibly has been the most palpable amongst uniquely vulnerable groups of patients, such as patients with a cancer diagn...
Lab-on-a-chip platforms enable advanced processing, manipulation, and analysis of biological samples in miniaturized fluidic devices. Despite the numerous advantages, such as lower reagent a...